By: Paul Fassa
Source: NaturalNews.com

The anti-depressant fraud toothpaste is out of the tube, at least partly. A Harvard Medical School psychologist, Irving Kirsch, who has been studying placebo effects for three decades, recently came up with the documented conclusion that pharmaceutical anti-depressants don’t work.

This is big news for many Natural News readers and writers. But this conclusion had the prescription-pad psychiatrists and FDA crying foul, loudly. Why? Kirsch’s conclusion was featured in a national CBS 60 Minutes television report.

Even more importantly, Kirsch’s conclusion was evidence based on documents from obtained using the Freedom of Information Act (FOIA). Those documents were trial results from drug companies that were not published and presented to the FDA.

Drug companies pay the FDA for approving their drugs. But the FDA doesn’t do the trials or reports. They simply take them from the drug companies who all do their own trials and decide which reports to publish and submit.

Kirsch discovered that most anti-depressant trials showed no proof of efficacy. Those results were simply hidden from view. So if 12 tests were done, and only two showed any efficacy at all, those two would be submitted to the FDA, and the FDA would essentially say “pay your fee and go to market.”

After analyzing the results of all the tests he was able to procure via FOIA, Kirsch concluded that anti-depressant drugs had only a placebo effect on patients with mild to moderate depression. In other words, a sugar pill would suffice. He went public with this conclusion.

CBS did a limited hangout

A limited hangout is intelligence spook speak for letting out just enough information to appease investigations or grass roots suspicions. But only part of the picture is revealed, not the whole big picture.

CBS did not reveal the horrible side effects from anti-depressants and psychotropic drugs. They did interview a British medical official who was part of a UK commission that banned anti-depressant use on mild to moderately depressed patients.

He reasoned that since most moderately depressed patients can be handled by talk therapy and physical exercise, why expose them to the risk of adverse effects. Sixty Minutes didn’t follow up on that angle.

Here in the States, where pharmaceuticals are advertised in newspapers and magazines, radio, and especially TV, anyone seeing happy actors proclaiming how and an anti-depressant changed their lives can almost demand that drug from even a primary care physician, and usually get it.

Even Medscape lists these side effects from SSRI and SNRI anti-depressants: Abnormal bleeding, hepatitis, headache, hyponatrenia (potentially deadly low sodium), toxic epidermal necrolysis (potentially deadly skin death), impotence, abnormal sensations, mania and suicide.

These are not your normal mild nausea or mild rash side effects. While some quit those drugs in time, the last few side effects especially have led to a very high rate of suicides and homicides among anti-depressant pill poppers.

As Heidi Stevenson of Gaia-Blog said, “Can we finally put to rest any claims from psychiatry that what they do is based on evidence, especially the so-called gold standard of placebo-controlled double blind studies … Please?”

To view the original article click here.
To reprint this article, visit the source website for reprinting guidelines